{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:21:57Z","timestamp":1787775717680,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a chronic, immune mediated demyelinating illness of the central nervous system. This study looks at various comorbidities associated with MS, focusing on their impact on disease progression. Understanding comorbidities in MS is important as it can impact treatment selection and overall disease management and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>Our aim is to show the prevalence of comorbidities along with MS. This research focuses on the comorbidities associated with MS and their impact on disease progression in the Arab Gulf region, with a special emphasis on Jeddah, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>A retrospective record review was conducted from July 2022 to July 2023. The study included 286 patients, selected based on a definitive MS diagnosis in accordance with McDonald\u2019s 2017 criteria. Data collected included demographic information, MS type, duration of diagnosis, type of disease modifying therapy (DMT) used, Expanded Disability Status Scale (EDSS) score, and type of comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The majority of the patients were female (70%) with an average age of 36 years. Most patients had relapsing remitting MS, and the majority were on DMTs, with fingolimod being the most common. Nearly half of the patients had comorbidities, with mood disorders, diabetes mellitus (DM), migraine, and hypertension (HTN) being prevalent. A significant positive association was found between the EDSS scores and both DM and HTN, but there was no significant link with migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings indicate that individuals with MS have an increased risk of developing comorbidities such as migraine, DM, and HTN. Emphasizing a healthy lifestyle could potentially reduce the incidence of DM and HTN and their related vascular complications. The research also notes the prevalence of mood disorders among the MS population, although it remains inconclusive whether these are separate comorbid conditions or inherent symptoms of MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_49_24","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T03:00:50Z","timestamp":1723604450000},"page":"600-605","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Prevalence of Comorbidities Associated with Multiple Sclerosis in Saudi Arabia"],"prefix":"10.4103","volume":"23","author":[{"given":"Hind","family":"Alnajashi","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Wali","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aqeeli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almothanna","family":"Magboul","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alfulayt","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Baasher","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"49.","DOI":"10.1186\/s12883-020-1629-3","article-title":"Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study","volume":"20","author":"AlJumah","year":"2020","journal-title":"BMC Neurol"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0035-3787(07)90484-1","article-title":"Neurorehabilitation in multiple sclerosis: An overview","volume":"163","author":"Donz\u00e9","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"a028928","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of multiple sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneur.63.4.614","article-title":"Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis","volume":"63","author":"Frohman","year":"2006","journal-title":"Arch Neurol"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000506161","article-title":"Risk of mortality in immigrants with multiple sclerosis in Ontario, Canada","volume":"54","author":"Rotstein","year":"2020","journal-title":"Neuroepidemiology"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: A review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMA Neurol"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.msard.2017.10.008","article-title":"The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults","volume":"19","author":"Graves","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archneur.63.12.1686","article-title":"Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: A systematic review","volume":"63","author":"Langer Gould","year":"2006","journal-title":"Arch Neurol"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.25011\/cim.v42i1.32383","article-title":"Comorbidity in multiple sclerosis: Past, present and future","volume":"42","author":"Marrie","year":"2019","journal-title":"Clin Invest Med"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"1197195.","DOI":"10.3389\/fimmu.2023.1197195","article-title":"Etiology, effects and management of comorbidities in multiple sclerosis: Recent advances","volume":"14","author":"Marrie","year":"2023","journal-title":"Front Immunol"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"851.","DOI":"10.3389\/fneur.2020.00851","article-title":"Comorbidity in multiple sclerosis","volume":"11","author":"Magyari","year":"2020","journal-title":"Front Neurol"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1352458509355461","article-title":"Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients","volume":"16","author":"Feinstein","year":"2010","journal-title":"Mult Scler"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/CLEP.S45305","article-title":"Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs","volume":"5","author":"Ording","year":"2013","journal-title":"Clin Epidemiol"},{"key":"R16-20260427","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1573399811666150724095130","article-title":"Diabetes mellitus in Saudi Arabia: A review of the recent literature","volume":"12","author":"Al Dawish","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/18756417OTg2dNzMaTcVY","article-title":"The worrying trend of diabetes mellitus in Saudi Arabia: An urgent call to action","volume":"16","author":"Robert","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"109119.","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"e3505.","DOI":"10.1002\/dmrr.3505","article-title":"Similarities and differences between multiple sclerosis and type 1 diabetes","volume":"38","author":"Pozzilli","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2337\/dc13-1414","article-title":"Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: Analysis from DPV database","volume":"37","author":"Bechtold","year":"2014","journal-title":"Diabetes Care"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"4948.","DOI":"10.3390\/jcm12154948","article-title":"The prevalence of diabetes mellitus type II (DMII) in the multiple sclerosis population: A systematic review and meta-analysis","volume":"12","author":"Giannopapas","year":"2023","journal-title":"J Clin Med"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1370\/afm.214","article-title":"Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000","volume":"3","author":"Koopman","year":"2005","journal-title":"Ann Fam Med"},{"key":"R23-20260427","doi-asserted-by":"crossref","first-page":"3086167.","DOI":"10.1155\/2018\/3086167","article-title":"Complications of diabetes 2017","volume":"2018","author":"Papatheodorou","year":"2018","journal-title":"J Diabetes Res"},{"key":"R24-20260427","first-page":"421","article-title":"Prevalence and most common causes of disability among adults \u2013 United States, 2005","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R25-20260427","first-page":"120","article-title":"Prevalence of disabilities and associated health conditions among adults \u2013 United States, 1999","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"41.","DOI":"10.1007\/s11906-021-01159-0","article-title":"Long-term trends in hypertension prevalence, awareness, treatment, and control rate in the Middle East and North Africa: A systematic review and meta-analysis of 178 population-based studies","volume":"23","author":"Mohammadian Khonsari","year":"2021","journal-title":"Curr Hypertens Rep"},{"key":"R27-20260427","doi-asserted-by":"crossref","first-page":"1092905.","DOI":"10.3389\/fpubh.2023.1092905","article-title":"National and regional prevalence rates of hypertension in Saudi Arabia: A descriptive analysis using the national survey data","volume":"11","author":"Alenazi","year":"2023","journal-title":"Front Public Health"},{"key":"R28-20260427","first-page":"557","article-title":"Hypertension Canada\u2019s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults","volume":"33","author":"Leung","year":"2017","journal-title":"Can J Cardiol"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","article-title":"Ageing and multiple sclerosis","volume":"22","author":"Graves","year":"2023","journal-title":"Lancet Neurol"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.neuroimage.2006.01.003","article-title":"Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processing","volume":"31","author":"Gianaros","year":"2006","journal-title":"Neuroimage"},{"key":"R31-20260427","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00415-006-0238-4","article-title":"Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure","volume":"254","author":"Firbank","year":"2007","journal-title":"J Neurol"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1212\/01.WNL.0000161871.83614.BB","article-title":"Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects","volume":"64","author":"Enzinger","year":"2005","journal-title":"Neurology"},{"key":"R33-20260427","first-page":"181","article-title":"Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis","volume":"87","author":"Kappus","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10194-010-0237-9","article-title":"Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course","volume":"11","author":"Kister","year":"2010","journal-title":"J Headache Pain"},{"key":"R35-20260427","doi-asserted-by":"crossref","first-page":"104152.","DOI":"10.1016\/j.msard.2022.104152","article-title":"Multiple sclerosis and migraine: Links, management and implications","volume":"68","author":"Mrabet","year":"2022","journal-title":"Mult Scler Relat Disord"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_49_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:26Z","timestamp":1787773226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_49_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_49_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"2024-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}